Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have remained a "blind spot" for treatment because antibodies cannot reach them.

A new lipid nanoparticle platform delivers full-length antibodies inside cells, unlocking intracellular targets in cancer, ...

Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have ...

A two-antibody cocktail that targets Nipah and Hendra’s receptor-binding and fusion proteins protects animals from lethal ...

The partnership is an extension of over 12 months of technical engagement between the two companies.

South Korean researchers have developed a new antibody capable of precisely targeting mutations in hard-to-treat cancers — ...

A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), ...

Discover how secondary antibodies enhance protein detection, improve assay sensitivity, and support reliable results across ...

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a research collaboration with the ...

Proteins that respond to external stimuli function as molecular switches, playing a vital role in the precise regulation of biological processes. Therefore, if protein switches could be artificially ...

FairJourney Bio ("FJBio"), a global antibody discovery expert, has announced the program for The Antibody Series (TAS) 2026, which will explore how insights from natural antibody repertoires, advances ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...